Abstract
Background: Leukoencephalopathy (LEP) is a type of disease producing a variety of neurologic disturbances, the most prominent of which is dementia. The aim of the present study is to test the modulatory effect of sinapic acid against toluene induced dementia of LEP type in rats.
Materials and Methods: The study was designed to induce dementia by inhalation of toluene vapours (0.7% in air for 15 min.) for a period of 14 days in rats and then divided among different groups, i.e. Treatment group, negative control and two groups of sinapic acid, (at a dose of 20 and 40mg/kg, p.o.). These groups were treated and observed until the 28th day of experimental trial. The avoidance/escape behaviour was measured via Pole Climbing Apparatus; spatial memory was measured via Morris Water Maze, and locomotion was measured via photoactometer (beam breaks). The behavioral, Neuronal and biochemical parameters were determined. The estimation of Monoamine Oxidase (MAO-A, MAO-B), TNF-α, Acetylcholine esterase Enzyme and various antioxidant enzymes (GSH, TBARS, Nitrite, Catalase) was done by methods available in literature. Histological changes in the brain were also observed.
Result: Rats receiving 40 mg/kg of sinapic acid showed a significant therapeutic activity against toluene induced dementia of LEP type in rats.
Conclusion: From the present experimental findings, it has been concluded that a dose of 40 mg/kg, (p.o.) of sinapic acid provides better neuromodulation in neurons against toluene induced dementia of LEP type in rats with a better choice of drug.
Keywords: Toluene induced dementia, sinapic acid, pharmacological, leukoencephalopathy, histopathological study, spatial memory.
The Natural Products Journal
Title:Modulatory Effect of Sinapic Acid in Toluene Induced Dementia of Leukoencephalopathy Type in Wistar Rats: a Biochemical Study
Volume: 8 Issue: 2
Author(s): Souravh Bais*Renu Kumari
Affiliation:
- Department of Pharmacology, Rayat Institute of Pharmacy, Railmajra,India
Keywords: Toluene induced dementia, sinapic acid, pharmacological, leukoencephalopathy, histopathological study, spatial memory.
Abstract: Background: Leukoencephalopathy (LEP) is a type of disease producing a variety of neurologic disturbances, the most prominent of which is dementia. The aim of the present study is to test the modulatory effect of sinapic acid against toluene induced dementia of LEP type in rats.
Materials and Methods: The study was designed to induce dementia by inhalation of toluene vapours (0.7% in air for 15 min.) for a period of 14 days in rats and then divided among different groups, i.e. Treatment group, negative control and two groups of sinapic acid, (at a dose of 20 and 40mg/kg, p.o.). These groups were treated and observed until the 28th day of experimental trial. The avoidance/escape behaviour was measured via Pole Climbing Apparatus; spatial memory was measured via Morris Water Maze, and locomotion was measured via photoactometer (beam breaks). The behavioral, Neuronal and biochemical parameters were determined. The estimation of Monoamine Oxidase (MAO-A, MAO-B), TNF-α, Acetylcholine esterase Enzyme and various antioxidant enzymes (GSH, TBARS, Nitrite, Catalase) was done by methods available in literature. Histological changes in the brain were also observed.
Result: Rats receiving 40 mg/kg of sinapic acid showed a significant therapeutic activity against toluene induced dementia of LEP type in rats.
Conclusion: From the present experimental findings, it has been concluded that a dose of 40 mg/kg, (p.o.) of sinapic acid provides better neuromodulation in neurons against toluene induced dementia of LEP type in rats with a better choice of drug.
Export Options
About this article
Cite this article as:
Bais Souravh *, Kumari Renu , Modulatory Effect of Sinapic Acid in Toluene Induced Dementia of Leukoencephalopathy Type in Wistar Rats: a Biochemical Study, The Natural Products Journal 2018; 8 (2) . https://dx.doi.org/10.2174/1570180815666171229154820
DOI https://dx.doi.org/10.2174/1570180815666171229154820 |
Print ISSN 2210-3155 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-3163 |
Call for Papers in Thematic Issues
Ayurvedic medicinal therapeutic approaches for inflammatory and neurodegenerative disorders
Usually, in our elderly population, neurodegenerative disorders occur due to neuron death. Alzheimer?s disease (AD) is an irreversible and progressive neurodegenerative disease. Dementia is the leading cause of AD, which affects about 30 million people worldwide. According to the World Alzheimer report 2018, a new case of dementia develops every ...read more
Recent Advances in Biotransformation of Bioactive Terpenoids using Aspergillus niger
Biotransformation is the reaction catalyzed by biological catalysts of either isolated enzymes or whole cell cultures of microorganisms. This process has been extensively applied in the conversion of bioactive terpenoids with high regio- and stereospecifity. This process has been also applied in the lead discovery and development. Aspergillus niger has ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Intracranial MR Dynamics in Clinically Diagnosed Alzheimers Disease: The Emerging Concept of “Pulse Wave Encephalopathy”
Current Alzheimer Research Mortality and Morbidity of HIV Infected Patients Receiving HAART: A Cohort Study
Current HIV Research Emerging Therapies in Relapsing-Remitting Multiple Sclerosis
Reviews on Recent Clinical Trials Autosomal Recessive Hereditary Spastic Paraplegia: A Rare Case of a Family with Phenotypic Variation
Current Pharmacogenomics and Personalized Medicine Pharmacotherapy and Prevention of Vascular Dementia
CNS & Neurological Disorders - Drug Targets Cerebral Hypoperfusion During Carotid Artery Stenosis can Lead to Cognitive Deficits that may be Independent of White Matter Lesion Load
Current Neurovascular Research Mouse Models of Multiple Sclerosis: Lost in Translation?
Current Pharmaceutical Design Immune Thrombocytopenic Purpura: New Biological Therapy of an Old Disease
Current Medicinal Chemistry Substance Abuse and Movement Disorders
Current Drug Abuse Reviews Cerebral Arachidonate Cascade in Dementia: Alzheimers Disease and Vascular Dementia
Current Neuropharmacology Progress of Biological Agents on Psoriatic Arthritis
Current Pharmaceutical Biotechnology The Role of the Oxysterol/EBI2 Pathway in the Immune and Central Nervous Systems
Current Drug Targets Targeting Notch as a Therapeutic Approach for Human Malignancies
Current Pharmaceutical Design Concurrent Use of Antiretrovirals and Anticonvulsants in Human Immunodeficiency Virus (HIV) Seropositive Patients
Current Pharmaceutical Design HIV-1-Associated Dementia During HAART Therapy
Recent Patents on CNS Drug Discovery (Discontinued) Treatment Options in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
Current Pharmaceutical Design Oral Agents in Multiple Sclerosis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Current Opinion in the Pharmaceutical Management of Irritable and Inflammatory Bowel Diseases: Role of ATP
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Hypertension in Pregnancy: Pathophysiology & Management Strategies
Current Pharmaceutical Design Disease Modifying Drugs in Multiple Sclerosis: Mechanisms of Action and New Drugs in the Horizon
CNS & Neurological Disorders - Drug Targets